Mesophilic dna polymerase extension blockers
AssigneeBecton, Dickinson and Company
InventorsDennis Prosen, Katherine Lazaruk
Life of this patent
Estimating the term…
Abstract
Disclosed herein include systems, methods, compositions, and kits for 5′-based gene expression profiling and for whole transcriptome analysis (WTA) with random priming and extension (RPE). Blocker oligonucleotides capable of specifically binding to a portion of an oligonucleotide barcode are provided in some embodiments. The blocker oligonucleotides can reduce of the generation of undesirable extension products, such as, for example, the extension products of random primers hybridized to a portion of the oligonucleotide barcode. Immune repertoire profiling methods are also provided in some embodiments.
Claims25
A method for labeling nucleic acid targets in a sample, comprising:
- contacting copies of a nucleic acid target with a plurality of oligonucleotide barcodes, wherein each oligonucleotide barcode comprises a first universal sequence, a molecular label, and a target-binding region capable of hybridizing to the nucleic acid target;
- extending the plurality of oligonucleotide barcodes hybridized to the copies of the nucleic acid target in the presence of a reverse transcriptase and a template switch oligonucleotide comprising the target-binding region, or a portion thereof, to generate a plurality of barcoded nucleic acid molecules each comprising a sequence complementary to at least a portion of the nucleic acid target, a first molecular label, the target-binding region, and a complement of the target-binding region;
- contacting the barcoded nucleic acid molecules with one or more blocker oligonucleotides capable of specifically binding to a portion of the oligonucleotide barcode;
- hybridizing the complement of the target-binding region of each barcoded nucleic acid molecule with the target-binding region of an oligonucleotide barcode of the plurality of oligonucleotide barcodes;
- and
- extending the 3′ ends of oligonucleotide barcodes hybridized to the complement of the target-binding region of the barcoded nucleic acid molecule to generate a plurality of extended barcoded nucleic acid molecules each comprising a complement of the first molecular label and a second molecular label, wherein the blocker oligonucleotides reduce the generation of extended barcoded nucleic acid molecules comprising a complement of the first universal sequence.
A kit comprising:
- a plurality of oligonucleotide barcodes, wherein each of the plurality of oligonucleotide barcodes comprises a first universal sequence, a cell label, a molecular label, and a target-binding region, and wherein at least 10 of the plurality of oligonucleotide barcodes comprise different molecular label sequences;
- one or more blocker oligonucleotides capable of specifically binding to a portion of the oligonucleotide barcode;
- a reverse transcriptase;
- a template switching oligonucleotide comprising the target-binding region, or a portion thereof;
- and
- a DNA polymerase lacking at least one of 5′ to 3′ exonuclease activity and 3′ to 5′ exonuclease activity.
A kit comprising:
- a plurality of oligonucleotide barcodes, wherein each of the plurality of oligonucleotide barcodes comprises a first universal sequence, a cell label, a molecular label, and a target-binding region, and wherein at least 10 of the plurality of oligonucleotide barcodes comprise different molecular label sequences;
- a plurality of random primers;
- one or more blocker oligonucleotides complementary to all or a portion of the first universal sequence and/or cell label;
- a DNA polymerase lacking at least one of 5′ to 3′ exonuclease activity and 3′ to 5′ exonuclease activity;
- and
- a reverse transcriptase.
Dependencies are inferred from the claim text.